Virulence factor distribution between patients with ITP and control patients
| . | cagA, no. (%) . | vacAs1, no. (%) . | s2, no. (%) . | m1, no. (%) . | m2, no. (%) . | iceA1, no. (%) . | A2, no. (%) . | babA2, no. (%) . |
|---|---|---|---|---|---|---|---|---|
| Patients with ITP | 7/10 (70) | 7/10 (70) | 3/10 (30) | 2/10 (20) | 8/10 (80) | 7/10 (70) | 4/10 (40) | 3/9 (33) |
| Control patients | 5/19 (26) | 9/19 (47) | 10/19 (53) | 4/19 (21) | 14/19 (74) | 11/19 (57) | 8/19 (42) | 9/17 (53) |
| P | .02 | .24 | .24 | .9 | .7 | .5 | .9 | .3 |
| . | cagA, no. (%) . | vacAs1, no. (%) . | s2, no. (%) . | m1, no. (%) . | m2, no. (%) . | iceA1, no. (%) . | A2, no. (%) . | babA2, no. (%) . |
|---|---|---|---|---|---|---|---|---|
| Patients with ITP | 7/10 (70) | 7/10 (70) | 3/10 (30) | 2/10 (20) | 8/10 (80) | 7/10 (70) | 4/10 (40) | 3/9 (33) |
| Control patients | 5/19 (26) | 9/19 (47) | 10/19 (53) | 4/19 (21) | 14/19 (74) | 11/19 (57) | 8/19 (42) | 9/17 (53) |
| P | .02 | .24 | .24 | .9 | .7 | .5 | .9 | .3 |